Trial Profile
A European, Retrospective, Observational Study Assessing the Safety and Effectiveness of Tenofovir Disoproxil Fumarate (TDF) or Entecavir (ETV) in Chronic Hepatitis B (CHB) Patients with Moderate or Severe Renal Impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2020
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 25 Jun 2020 Results published in the Alimentary Pharmacology and Therapeutics
- 14 May 2018 New trial record
- 14 Apr 2018 Results presented at The International Liver Congress 2018.